These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 17261305)

  • 21. Effects of varying serum glucose levels on 18F-FDG biodistribution.
    Webb RL; Landau E; Klein D; DiPoce J; Volkin D; Belman J; Voutsinas N; Brenner A
    Nucl Med Commun; 2015 Jul; 36(7):717-21. PubMed ID: 25888357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computer phantom study of brain PET glucose metabolism imaging using a rotating SPECT/PET camera.
    McGoron AJ; Mao X; Georgiou MF; Kuluz JW
    Comput Biol Med; 2005 Jul; 35(6):511-31. PubMed ID: 15780862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reactive lymphoid hyperplasia of the liver identified by FDG PET.
    Lin E
    Clin Nucl Med; 2008 Jun; 33(6):419-20. PubMed ID: 18496452
    [No Abstract]   [Full Text] [Related]  

  • 24. Normal variants in [18F]-fluorodeoxyglucose PET imaging.
    El-Haddad G; Alavi A; Mavi A; Bural G; Zhuang H
    Radiol Clin North Am; 2004 Nov; 42(6):1063-81, viii. PubMed ID: 15488558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heavy PETting: reducing radiation exposure from intradepartment positron emission tomography scans.
    Bornstein S; Young K; Tanyi J; Holland J
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):545. PubMed ID: 24368063
    [No Abstract]   [Full Text] [Related]  

  • 26. Visualization of early engraftment in clinical islet transplantation by positron-emission tomography.
    Eich T; Eriksson O; Lundgren T;
    N Engl J Med; 2007 Jun; 356(26):2754-5. PubMed ID: 17596618
    [No Abstract]   [Full Text] [Related]  

  • 27. Quantification of [(18)F]FDG uptake in the normal liver using dynamic PET: impact and modeling of the dual hepatic blood supply.
    Brix G; Ziegler SI; Bellemann ME; Doll J; Schosser R; Lucht R; Krieter H; Nosske D; Haberkorn U
    J Nucl Med; 2001 Aug; 42(8):1265-73. PubMed ID: 11483690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Horizontal versus longitudinal axis of the hippocampus: metabolic differentiation as measured with high-resolution PET/MRI.
    Yakushev I; Fellgiebel A
    J Nucl Med; 2011 Feb; 52(2):329; author reply 329-30. PubMed ID: 21233184
    [No Abstract]   [Full Text] [Related]  

  • 29. Metabolic evidence of myocardial stunning in takotsubo cardiomyopathy: a positron emission tomography study.
    Obunai K; Misra D; Van Tosh A; Bergmann SR
    J Nucl Cardiol; 2005; 12(6):742-4. PubMed ID: 16344237
    [No Abstract]   [Full Text] [Related]  

  • 30. [Variations of the hepatic SUV in relation to the body mass index in whole body PET-CT studies].
    Batallés SM; Villavicencio RL; Quaranta A; Burgos L; Trezzo S; Staffieri R; Pezzotto SM
    Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):26-32. PubMed ID: 23177341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in rat models with hepatocellular carcinoma with liver cirrhosis.
    Park SI; Lee JH; Ham HJ; Jung YJ; Park MS; Lee J; Maeng LS; Chung YA; Jang KS
    Biomed Mater Eng; 2015; 26 Suppl 1():S1669-76. PubMed ID: 26405933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased glucose uptake by seborrheic keratosis detected by positron emission tomography.
    Ibusuki A; Higashi Y; Kanekura T
    J Dermatol; 2011 Jan; 38(1):104-5. PubMed ID: 21175767
    [No Abstract]   [Full Text] [Related]  

  • 33. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Vallabhajosula S
    Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different glucose uptake and glycolytic mechanisms between hepatocellular carcinoma and intrahepatic mass-forming cholangiocarcinoma with increased (18)F-FDG uptake.
    Lee JD; Yang WI; Park YN; Kim KS; Choi JS; Yun M; Ko D; Kim TS; Cho AE; Kim HM; Han KH; Im SS; Ahn YH; Choi CW; Park JH
    J Nucl Med; 2005 Oct; 46(10):1753-9. PubMed ID: 16204727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapeutic response evaluation by nuclear functional imaging].
    Moretti JL; Hindie E; Vercellino L
    Bull Cancer; 2007; 94(7 Suppl):F241-4. PubMed ID: 17965003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemidystonia in uncontrolled type 2 diabetes mellitus.
    Striano P; Caranci F; Pappatà S; Zara F; Striano S
    Arch Neurol; 2011 May; 68(5):674. PubMed ID: 21555647
    [No Abstract]   [Full Text] [Related]  

  • 37. A pathophysiological study of tako-tsubo cardiomyopathy with F-18 fluorodeoxyglucose positron emission tomography.
    Ramaraj R
    Eur Heart J; 2008 Mar; 29(5):681; author reply 681-2. PubMed ID: 18238929
    [No Abstract]   [Full Text] [Related]  

  • 38. Monitoring plaque composition: is it worthwile?
    van der Laarse A; van der Wall EE
    Int J Cardiovasc Imaging; 2009 Mar; 25(3):259-61. PubMed ID: 19037748
    [No Abstract]   [Full Text] [Related]  

  • 39. Cholescintigraphic measurement of liver function: how is it different from other methods?
    Krishnamurthy GT; Krishnamurthy S
    Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1103-6. PubMed ID: 16858567
    [No Abstract]   [Full Text] [Related]  

  • 40. Imaging patterns of liver uptakes on PET scan: pearls and pitfalls.
    Luk WH; Au-Yeung AW; Loke TK
    Nucl Med Rev Cent East Eur; 2013; 16(2):75-81. PubMed ID: 24068637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.